HER 2 immunohistochemistry for breast cancer cell blocks can be used in the same way as that used for histological specimens

BACKGROUND: Human epidermal growth factor receptor 2 (HER2) testing of samples from recurrent or metastatic breast cancer is recommended by the 2013 update of the American Society of Clinical Oncology/College of American Pathologists guidelines. Although cytological analysis can be applied to severa...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Rieko, Okamoto, Nami, Satou, Masakazu, Kojima, Kenta, Tanaka, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819718/
https://www.ncbi.nlm.nih.gov/pubmed/26800514
http://dx.doi.org/10.1002/dc.23433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819718/
https://www.ncbi.nlm.nih.gov/pubmed/26800514
http://dx.doi.org/10.1002/dc.23433

Ejemplares similares